Articles

American manufacturers were among the first U.S. businesses to show damage from President Trump’s trade wars. And they are still showing lots of stress even after the White House relaxed most tariffs.

How to tell your children you plan to “die with zero.”

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Campbell’s said its Food & Beverage unit booked a 15% jump in sales on strength in products such as Rao’s tomato sauce.

Long-term focused “M/O ratio” — or “Middle-Old ratio” — sees a peak for the S&P 500 and opportunity in emerging markets.

Having posted world-beating returns so far in 2025, Polish stocks fell sharply on Monday as right-wing PiS candidate narrowly wins presidential election.

‘Sell America’ trade leaves gold buyers with just one question: How much?

There’s a new addition to the ever-expanding lexicon of Trump trades, says Nomura

“She treats my sibling and me as virtual strangers.”

U.S. workers are not sure whether to buy that new car — or brace for a recession.

Federated Hermes’s Steve Chiavarone crystalized the market’s view of where the Federal Reserve is heading on interest rates in one sentence.

Goldman Sachs took a look at rising bond yields and concluded that they’re still not a threat to the S&P 500 this year.